Novo Nordisk activities at ATTD 2024

Novo Nordisk activities at ATTD 2024

The intersection of once-weekly insulins and digital health technologies

Friday 8 March 2024, 15.15–16.45 CET, Hall A

The Novo Nordisk industry symposium at ATTD 2024 chaired by Julio Rosenstock, MD (USA), will feature speakers Yvonne Winhofer, MD (Austria), Harpreet S. Bajaj, MD (Canada) and Thomas Danne, MD (Germany).

This symposium will focus on novel insulins and digital health for diabetes management. The expert panel will address some of the key challenges and benefits that once-weekly insulins and digital health technologies can provide, as well as factors to consider for constructing individualised treatment plans in people with T1D or T2D.

On behalf of the Chair and faculty, we hope you can join us on Friday 8 March 2024, at 15.15–16.45 CET onsite or online for an engaging session.

Please watch the video below featuring the symposium Chair, Julio Rosenstock, for a brief teaser of what you can look forward to at the symposium.

Explore Novo Nordisk’s exciting innovations within Digital Health at ATTD 2024 in Florence, Italy, and online.

Thursday 7 March at 10.15-10.30 CET and Friday 8 March at 13:15-13.30 CET at Booth 75.

Join us at Booth 75 for live demonstrations of digital health innovations, booth swaps with our global partners and the first of our DigitalTalk series featuring Malin Johansson (VP Digital Health Partnerships and Commercialisation, Novo Nordisk) and Eric Dessertenne (CEO, Biocorp). They’ll be discussing the value of add-on connectivity in diabetes management.